» Articles » PMID: 31001120

Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR Pathway

Overview
Journal Front Pharmacol
Date 2019 Apr 20
PMID 31001120
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Zinc doped copper oxide nanocomposites (Zn-CuO NPs) is a novel doped metal nanomaterial synthesized by our group using the sonochemical method. Our previous studies have shown that Zn-CuO NPs could inhibit cancer cell proliferation by inducing apoptosis via ROS-mediated pathway. In the present study, we studied the anticancer effect of Zn-CuO NPs on human pancreatic cancer cells. MTS assay revealed that Zn-CuO NPs was able to inhibit cancer cell growth. TEM, flow cytometry and fluorescence microscope analysis showed that Zn-CuO NPs induced autophagy significantly; the number of autophagosomes increased obviously in cells treated with Zn-CuO NPs. Western blot analysis revealed that treatment with the NPs resulted in activation of AMPK/mTOR pathway in both AsPC-1 and MIA Paca-2 cells in dose dependent manners. Moreover, in the presence of AMPK activator AMPKinone, the protein level of p-AMPK, p-ULK1, Beclin-1 and LC3-II/LC3-I increased, while the protein expression of p-AMPK, p-ULK1, Beclin-1 and LC3-II/LC3-I decreased in the presence of AMPK inhibitor Compound C. study using xenograft mice revealed that Zn-CuO NPs significantly inhibited tumor growth with low toxicity. Our study confirms that Zn-CuO NPs inhibit the tumor growth both and for pancreatic cancer. AMPK/mTOR pathway plays an important role in the NPs induced inhibition of tumor growth.

Citing Articles

Mechanisms of Copper-Induced Autophagy and Links with Human Diseases.

Fu Y, Zeng S, Wang Z, Huang H, Zhao X, Li M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861161 PMC: 11768742. DOI: 10.3390/ph18010099.


Trace elements in pancreatic cancer.

Yanjun Y, Jing Z, Yifei S, Gangzhao G, Chenxin Y, Qiang W Cancer Med. 2024; 13(14):e7454.

PMID: 39015024 PMC: 11252496. DOI: 10.1002/cam4.7454.


Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.

Huang Y, Gong P, Su L, Zhang M Sci Rep. 2023; 13(1):20870.

PMID: 38012210 PMC: 10682027. DOI: 10.1038/s41598-023-47223-4.


Micelle encapsulation zinc-doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair.

Yi J, Luo X, Xing J, Gedanken A, Lin X, Zhang C Bioeng Transl Med. 2023; 8(3):e10507.

PMID: 37206208 PMC: 10189445. DOI: 10.1002/btm2.10507.


Cu-doped TiO nanoparticles improve local antitumor immune activation and optimize dendritic cell vaccine strategies.

Hesemans E, Saffarzadeh N, Maksoudian C, Izci M, Chu T, Luci C J Nanobiotechnology. 2023; 21(1):87.

PMID: 36915084 PMC: 10009859. DOI: 10.1186/s12951-023-01844-z.


References
1.
Kondo Y, Kanzawa T, Sawaya R, Kondo S . The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005; 5(9):726-34. DOI: 10.1038/nrc1692. View

2.
White E, DiPaola R . The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 2009; 15(17):5308-16. PMC: 2737083. DOI: 10.1158/1078-0432.CCR-07-5023. View

3.
Rasmussen J, Martinez E, Louka P, Wingett D . Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv. 2010; 7(9):1063-77. PMC: 2924765. DOI: 10.1517/17425247.2010.502560. View

4.
Baek Y, An Y . Microbial toxicity of metal oxide nanoparticles (CuO, NiO, ZnO, and Sb2O3) to Escherichia coli, Bacillus subtilis, and Streptococcus aureus. Sci Total Environ. 2011; 409(8):1603-8. DOI: 10.1016/j.scitotenv.2011.01.014. View

5.
Rosenfeldt M, Ryan K . The multiple roles of autophagy in cancer. Carcinogenesis. 2011; 32(7):955-63. PMC: 3128556. DOI: 10.1093/carcin/bgr031. View